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Abstract The present research was undertaken to study the 
possible involvement of the atypical protein kinase C (PKC) Ç in 
ceramide signal transduction in primary cultures of rat astro-
cytes. As shown by Western blot analysis, translocation of 
imnuinoreactive PKC Ç to the particulate fraction occurred upon 
exposure of astrocytes to cell-permeable ceramide analogs or to 
exogenous sphingomyelinase. The particulate fraction may 
correspond to a perinuclear area, as indicated by immunocyto-
chemical techniques. Furthermore, treatment of cells with N-
octanoylsphingosine led to an increased phosphorylation of 
PKCÇ. Results thus show that stimulation of PKCÇ may be 
one of the intracellular events triggered by activation of the 
sphingomyelin pathway. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Sphingolipids are currently recognized as active participants 
in the regulation of a wide range of cellular responses such as 
regulation of cell growth, differentiation, transformation and 
death [1]. Sphingomyelin (SM) breakdown occurs in multiple 
cell types in response to a variety of extracellular mediators 
including cytokines e.g. tumor necrosis factor a (TNFoc), in-
terleukin-lß (IL-Iß), interferon-y and other agents such as 
nerve growth factor (NGF), la,25-dihydroxyvitamin D3, 
Fas ligand and ionizing radiation (reviewed in [1-3]). Recep-
tor-mediated hydrolysis of SM generates ceramide, which may 
function as a second messenger activating several serine/threo-
nine protein kinases and phosphatases [4]. Among the former, 
one of the atypical isoforms of protein kinase C (PKC), 
PKCÇ, has been proposed as an intracellular target of ceram-
ide action [5,6]. These atypical PKC members (Ç and ÀA) are 
dependent on phosphatidylserine but are not affected by diac-
ylglycerol, phorbol esters or Ca2+ [7,8]. Although PKCÇ has 
been shown to be involved in the control of a number of 
cellular functions including mitogenic signal transduction [9], 
neuronal differentiation [10] and long-term potentiation [11], 
the signal mechanisms downstream PKCÇ activation are not 
well known. PKCÇ has been suggested to play a role in the 
activation of the mitogen-activated protein kinase (MAPK) 
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pathway [12]. PKC¡¡ has also been shown to be involved in 
the activation of nuclear factor KB ( N F - K B ) , which is a land-
mark of the TNFcc mechanism of action. Little is known 
about the specific signal transduction pathways linking TNF 
receptors to N F - K B . A connection has been proposed between 
TNFoc receptor and phosphatidylcholine phospholipase C 
(PC-PLC), which is coupled to sphingomyelinase (SMase), 
resulting in the generation of ceramide [6,13,14]. We have 
recently demonstrated that PC-PLC induces cellular redistrib-
ution and phosphorylation of PKCÇ in glial cells [15]. The 
present work was thus undertaken to test whether PKCÇ 
may also be a target for ceramide action in primary cultures 
of astrocytes. 
2. Materials and methods 
2.1. Materials 
Anti-PKCÇ antibody, raised against amino acids 577-592 of rat 
PKCÇ, was from Life Technologies Inc. (Gaithesburg, MD, USA). 
Fluorescein-conjugated donkey anti-rabbit IgG was from Amersham 
(Little Chaltfont, UK). D-erythro-A -^acetylsphingosine (C2-ceramide), 
D-erythro-iV-octanoylsphingosine (Cg-ceramide) and D-erythro-dihy-
dro-JV-acetylsphingosine (DHC) were from Calbiochem (La Jolla, 
CA, USA). Protein A-agarose was from Transduction Laboratories 
(Lexington, KY, USA). Neutral SMase (S. aureus) and all other re-
agents were from Sigma Chemicals (St Louis, MO, USA). 
2.2. Primary cultures of astrocytes 
Cortical astrocytes were derived from 1-2 day old rats and cultured 
as previously described [16]. Cells were seeded at a density of 3 X 104 
cells/cm2 on plastic plates previously coated with 5 ug/ml dl-polyor-
nithine in water. The primary cultures consisted of 95% astrocytes as 
judged by immunocytochemical staining of glial flbrillary acidic pro-
tein. 
Three days before the experiment, the serum-containing medium 
was removed and cells were transferred to a chemically defined me-
dium consisting of serum-free DMEM:Ham's F12 (1:1, v:v) medium 
supplemented with 25 ug/ml insulin, 50 ug/ml human transferrin, 20 
nM progesterone, 50 uM putrescine, and 30 nM sodium selenite. 
2.3. Western blot analysis of PKCÇ 
After stimulation, cells were washed with ice-cold PBS and subse-
quently homogenized in 50 mM Tris-HCl, pH 7.5, containing 5 mM 
EDTA, 1 mM EGTA, 10 mM ß-mercaptoethanol, 1 mM PMSF, 5 ug/ 
ml leupeptin, 2 ug/ml aprotinin, 10 |ig/ml soybean trypsin inhibitor 
and 10 ug/ml benzamidine. Soluble and particulate fractions were 
obtained after centrifugation for 60 min at 40000Xg. Proteins were 
then resolved by SDS-PAGE and transferred onto nitrocellulose. Im-
munodetection of PKCÇ was carried out by incubating membranes 
with anti-PKCÇ polyclonal antibody and developing with an enhanced 
chemiluminescence reaction kit (Amersham). 
2.4. Immunocytochemical procedures 
Astrocytes were grown in glass coverslips in serum-containing me-
dium and at three weeks made quiescent by serum starvation. Cells 
were stimulated with different agents, washed with phosphate buffer 
saline (PBS) and coverslips immediately immersed in 3.7% formalde-
hyde/PBS for 5 min. After washing in PBS, cells were treated with 
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0.05% Triton X-100 and subsequently incubated with 40 u.g/ml poly-
clonal anti-PKCÇ antibody for 60 min and fluorescein-conjugated 
anti-rabbit IgG for 60 additional min. Coverslips were then mounted 
with glycerol containing 0.1% p-phenylenediamine and subjected to 
fluorescence microscopy. 
2.5. Phosphorylation of PKCÇ 
Phosphorylation of PKCÇ was performed after loading of cells with 
32 Pi and immunoprecipitation as previously described [17]. Immuno-
precipitation was carried out by incubation with 7.5 ug/ml of anti-
PKCÇ polyclonal antibody and precipitation with agarose-linked pro-
tein A. Phosphorylation was determined in the immunoprecipitates by 
SDS-PAGE and autoradiography. Gels were previously stained with 
Coomasie blue in order to verify the appropriate loading of the gels. 
Autoradiography Fuji films were subjected to densitometric analysis 
using the Sigma-Gel program. 
3. Results and discussion 
3.1. Translocation of PKCÇ and identification by 
immunoblotting 
To study whether SMase and ceramides may have an effect 
on the subcellular distribution of PKCÇ, primary cultures of 
astrocytes were treated with neutral SMase or cell-permeable 
ceramide analogs, C2-ceramide and Cs-ceramide. As shown in 
Fig. 1, PKCÇ appears to be expressed in primary cultures of 
astrocytes as a single 75 kDa isoform in both the particulate 
and the soluble fraction, with approximately equal amounts of 
total enzyme in each fraction in non-stimulated cells (55% and 
45% respectively) [18]. Cs- and C2-ceramide, as well as exog-
enous SMase, induced a significant increase in immunoreac-
tive PKCÇ in the particulate fraction with a concomitant de-
crease in the soluble fraction (Fig. 1). The time course of Cg-
ceramide-induced PKCÇ translocation to the particulate frac-
Fig. 1. Localization of PKCÇ by immunoblotting. Astrocytes were 
stimulated with vehicle, 1 U/ml SMase (S. aureus), 25 uM Cg-cer-
amide or 25 uM C2-ceramide for 15 min. The upper panel shows a 
representative luminogram of the immunoblots. The lower panel 
shows the means ± S.D. of densitometric analyses from three inde-
pendent experiments expressed in arbitrary units referred to densito-
metric units from control cells. Statistical analysis was performed by 
Student's Mest. Significantly different vs. the corresponding subcel-
lular fraction of control cells: *: P< 0.025; **: P < 0 . 0 1 . 
Fig. 2. Time course of Cg-ceramide-induced translocation of PKCÇ. 
Astrocytes were stimulated with 25 uM Cg-ceramide for 0, 5, 15, 60 
and 180 min. The upper panel shows a representative luminogram 
of the immunoblots. The lower panel shows the means ± S.E.M. of 
densitometric analyses from two independent experiments expressed 
in arbitrary units referred to densitometric units from control cells. 
tion is shown in Fig. 2. PKCÇ redistribution was already 
evident after 5 min treatment and was maximal after 15 min 
of ceramide stimulation. These findings indicate that activa-
tion of the SM pathway induces PKCÇ translocation to the 
particulate fraction of rat astrocytes. 
3.2. Redistribution of PKCÇ in primary astrocytes 
To further study the intracellular localization of PKCÇ, 
immunocytochemical analyses were performed. As shown in 
Fig. 3, exposure of cells to either SMase or ceramide analogs 
induced PKCÇ translocation to a perinuclear area. The effect 
of added SMase indicates that endogenously produced ceram-
ides are also able to induce PKCÇ cellular redistribution, 
therefore corroborating the specificity of ceramide analog ac-
tion. Perinuclear signal was stronger in SMase-treated and C$-
ceramide-treated cells (Fig. 3C and D) than in C2-ceramide 
(Fig. 3E). This may be probably due to the longer alkyl chain 
of the former, which makes it more similar to natural occur-
ring ceramides. Like in Western blot analysis (see above), Cg-
ceramide and SMase-generated ceramides produced a greater 
effect than the short chain C2-ceramide. Therefore alkyl chain 
length may play an important role in ceramide action. This 
effect has also been observed in raf-1 activation by ceramides 
[19]. The emerging hypothesis from this observations is that 
such structural requirements may explain divergent effects of 
different ceramides as a consequence of its subcellular origin, 
and the specific SM pool involved [20]. In this context, a 
different action of intracellularly generated ceramides and 
exogenously added ceramides in the induction of apoptosis 
has been recently reported [21]. 
The specificity of the effect of ceramides is supported by the 
fact that inactive ceramide analog DHC did not induce any 
change in the subcellular localization of PKCÇ (Fig. 3B). 
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Fig. 3. Immunofluorescence localization of PKCÇ in primary astrocytes. Cells were stimulated for 15 min with vehicle (A); 25 uM DHC (B); 
1 U/ml SMase (S. aureus) (C); 25 |J.M Cg-ceramide (D) and 25 |J,M C2-ceramide (E). 
These data are in line with previous observations by other 
authors who have also found PKCÇ located in a perinuclear 
area in intimate association with the ß-tubulin fraction of the 
cytoskeleton [22,23]. PKCÇ has also been found associated to 
the Golgi apparatus and probably involved in the formation 
of transport vesicles [24]. 
3.3. Phosphorylation state of PKCÇ 
PKC translocation has been related to its functional state 
[8]. One of the molecular events observed during PKC activa-
tion is an increase in its phosphorylation state [25]. To inves-
tigate the effect of ceramides in the phosphorylation level of 
PKCÇ, astrocyte cultures were incubated with 32P¡, and then 
immunoprecipitation studies were carried out. Fig. 4 shows 
that short-term treatment with ceramide analogs induced an 
increase in the phosphorylation state of PKCÇ, that was spe-
cific for biologically active ceramide analogs, as shown by the 
lack of effect of DHC. Subcellular redistribution of PKCÇ to 
the particulate cell fraction was in the same interval of time 
than ceramide-induced increase of PKCÇ phosphorylation, in-
dicating that both events may be related. 
The precise mechanism of the regulation of PKCÇ activity is 
still controversial. Contradictory results have been reported 
regarding the subcellular redistribution of PKCÇ upon activa-
tion. Numerous reports indicate that active PKCÇ is found 
concentrated in membrane fractions or cytoskeleton structures 
[15,22,24,26]. Translocation of PKCÇ from the cytosol to nu-
clear myofibrilar fraction occurs in the ischémie fetal brain 
[27]. However, recent data have shown a translocation of 
activated PKCÇ to the cytoplasm, with a concomitant increase 
in the phosphorylation state and activity of the enzyme in 
response to changes in intracellular cAMP levels [28]. This 
indicates that the phosphorylated enzyme would display a 
diminished membrane affinity [8]. Association of PKCÇ with 
both cytosol and membranes may be mediated through a 
recently identified protein kinase C-binding protein, i.e. zeta-
interacting protein which has been shown to interact with the 
regulatory domain of the kinase [29]. 
The importance of ceramide signaling in rat astrocytes has 
been evidenced in our laboratory by the fact that ceramide 
analogs, SMase and PC-PLC induce NGF production in these 
glial cells [16,17]. We report here that both SMase and ceram-
ide analogs induce the translocation of PKCÇ to a perinuclear 
membrane region and increase the PKCÇ phosphorylation 
level, suggesting the possible involvement of PKCÇ in ceram-
ide signaling in primary cultures of rat astrocytes. 
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